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Abstract.  Calcium release from intracellular stores is 
the signal generated by numerous regulatory pathways 
including those mediated by hormones, neurotransmit- 
ters and electrical activation of muscle. Recently two 
forms of intracellular calcium release channels (CRCs) 
have been identified. One, the inositol 1,4,5-trisphos- 
phate receptors (IP3Rs)  mediate IP3-induced Ca  2+ re- 
lease and are believed to be present on the ER of 
most cell types. A second form, the ryanodine recep- 
tors (RYRs) of the sarcoplasmic reticulum, have evolved 
specialized functions relevant to muscle contraction 
and are the major CRCs found in striated muscles. 
Though structurally related, IP3Rs and RYRs have dis- 
tinct physiologic and pharmacologic profiles.  In the 
heart, where the dominant mechanism of intracellular 
calcium release during excitation-contraction coupling 
is Ca2+-induced Ca  2+ release via the RYR,  a role for 
IP3-mediated Ca  2+ release has also been proposed.  It 
has been assumed that IP3Rs are expressed in the heart 
as in most other tissues, however,  it has not been pos- 
sible to state whether cardiac IP3Rs were present in 
cardiac myocytes (which already express abundant 
amounts of RYR) or only in non-muscle cells within 
the heart. This lack of information regarding the ex- 
pression and structure of an IP3R within cardiac myo- 
cytes has hampered the elucidation of the significance 
of IP3 signaling in the heart. In the present study we 
have used combined in situ hybridization to IP3R 
mRNA and immunocytochemistry to demonstrate that, 
in addition to the RYR, an IP3R is also expressed in 
rat cardiac myocytes. Immunoreactivity and RNAse 
protection have shown that the IP3R expressed in car- 
diac myocytes is structurally similar to the IP3R in 
brain and vascular smooth muscle. Within cardiac myo- 
cytes, IP3R mRNA levels were ,,o50-fold lower than 
that of the cardiac RYR mRNA. Identification of an 
IP3R in cardiac myocytes provides the basis for future 
studies designed to elucidate its functional role both as 
a mediator of pharmacologic and hormonal influences 
on the heart, and in terms of its possible interaction 
with the RYR during excitation-contraction coupling 
in the heart. 
I 
NOSITOL  1,4,5-trisphosphate  (IP3) 1 is  an  important 
second messenger regulating intracellular Ca  2+ concen- 
tration (Berridge and Irvine  1984; 1989). Membrane 
receptor  activation  leading  to  G-protein-coupled  phos- 
phoinositide hydrolysis results in the generation of IP3 and 
subsequent  release  of Ca  2+  from  ER  stores.  Significant 
advances in understanding the molecular basis of IP3-stim- 
ulated intracellular  Ca  2+ release have been made in recent 
years. Chief among these has been the identification of the 
inositol  1,4,5-trisphosphate receptors  (IP3R) which are in- 
tracellular calcium release channels on the ER. In many cell 
types the IP3 signaling pathway is the primary mechanism 
governing intracellular  calcium release.  In contrast,  in the 
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heart the major pathway for intracellular calcium release in- 
volves the ryanodine receptor  (RYR) on the sarcoplasmic 
reticulum (reviewed in Bers,  1991). The RYR is a member 
of  the same gene family as the IP3R, but has evolved special- 
ized functions relevant to excitation-contraction  coupling in 
striated muscles (Fleischer and Inui, 1989; Catterall,  1991). 
It has been proposed that hormonal regulation of cardiac 
contractility may be mediated by IP3-induced intracellular 
calcium release. However, in the two types of cells which al- 
ready contain a major non-IP3-responsive pathway for intra- 
cellular calcium release (the RYRs in cardiac and skeletal 
muscle) it has not previously been established that IP3Rs are 
expressed, nor has the structure of  the IP3Rs in striated mus- 
cle  been  characterized.  Indeed,  the  significance  of IP3- 
induced intracellular calcium release in the heart has been 
hotly debated in recent years. This debate has focused on 
conflicting data (summarized below) regarding the effects of 
IP3 on cardiac muscle contraction and calcium release. 
In the present study we have used combined in situ hybrid- 
ization and immunocytochemistry  to demonstrate  conclu- 
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have shown that a single cell type, cardiac myocytes, express 
both  forms of calcium  release  channels  characterized to 
date, IP3R and RYR. On the basis of immunoreactivity and 
RNAse protection we have demonstrated that the cardiac 
IP3R is structurally similar to that expressed in the brain and 
vascular smooth muscle. These findings form the basis for 
further studies designed to elucidate the molecular events as- 
sociated with IP3 signaling in cardiac myocytes. 
Materials and Methods 
cDNA Cloning and Sequencing 
A 946-bp mouse aortic smooth muscle IP3R eDNA (Marks et al.,  1990) 
was used for Northern blot analyses (see below) and to isolate a  1.7-kb 
rat aortic smooth muscle IP3R eDNA (R-IP3R-1)  from a random primed 
rat aortic smooth muscle eDNA library constructed in X ZAP II (a gift from 
Dr.  Mark Tanbman, Mount Sinai School of Medicine, New York,  NY). 
This 1.7-kb eDNA, R-IP3R-1, was sequenced using the dideoxy chain termi- 
nation methodology and an automated sequencer (model 373;  ABI Adv. 
Biotechnologies, Inc., Columbia, MD). Sequences were edited and com- 
pared to the Genbank database using MacVector software (v3.5.3).  Com- 
pared to the mouse aortic smooth muscle IP3R (Marks et al., 1990) R-IP3R-1 
corresponded to nuclcotides 98%2705.  The procedures used for library 
screening and isolation of  eDNA clones were performed as described previ- 
ously (Marks et al.,  1989). 
RNA Preparation, RNAse Protection, and 
Northern Blot Analysis 
RNA was prepared from rat tissue ground with a tissue-mizer (Tekrnar, Cin- 
cinnati, OH) then purified using standard guanidinium-thiocya ate lysis 
buffer and centrifugation through a cesium chloride cushion as previously 
described (Marks  et al.,  1989).  RNA was  size separated on formalde- 
hyde/agarose gels and Northern blot transfer was carried out overnight using 
10x SSC. Northern blot analysis was as previously described (Marks et al., 
1989);  hybridization was performed at 42~  overnight and washing was at 
55~  in 0.2x  SSC. Northern blot analysis was performed with an IP3R 
eDNA probe corresponding to the sequence of the cRNA probe used for 
in situ hybridization to demonstrate that this probe only hybridized to a sin- 
gle mRNA of 10 kb in size. Films were autoradiographed with a single in- 
tensifying screen at  -70~ 
RNAse protection was performed using the same cRNA probes (sense 
and antisense) as those used for in situ hybridization (see below) except that 
the radionucleotide was 32p instead of 35S. Total RNA samples from adult 
rat were hybridized overnight at 45~  with 8  x  104 cpm of the respective 
radiolabeled riboprobe using reagents from a ribonuclease protection assay 
kit (Ambion Inc., Austin, TX)  following the recommended procedures. 
Samples were resuspended in 50% deionized formamide, heated at 95~ 
and electrophoresed in 6-8% denaturing polyacrylamide gels. 
Northern blot analyses were performed with the following probes: (a) 
IP3R1,  a 946-bp mouse aortic smooth muscle IP3R eDNA corresponding 
to nucleotides 817 to 1763 of  the mouse brain IP3R sequence (Marks et al., 
1990);  (b) HCRC1,  a 580-bp rabbit cardiac RYR eDNA corresponding to 
nucleotides 5027-5647  of  the eDNA encoding the rabbit cardiac RYR (Bril- 
lantes  et  al.,  1992);  (c)  the  glyceraldehyde-3-phosphate-dehydrogenase 
(GAPDH) probe was a  1.3-kb  PstI fragment from clone pUC-GAPDH13 
containing the entire coding region and part of the 3'-untranslated region 
of the rat GAPDH (Fort et al.,  1985).  All probes were uniformly labeled 
with random primers using Klenow and if_p32 dCTP to a specific activity 
of >109 cpm per/~g, mRNA levels were determined by Northern blot anal- 
yses using laser densitometry and the Image 1.36 software for data analysis 
on a Macintosh computer. 
Antibody Preparation and Western Blot Analysis 
A  synthetic peptide,  IP3R2690,  based on the  sequence of amino  acid 
residues 2690-2700  ([Cys]-Glu-Gln-Asn-Glu-Leu-Arg-Asn-Leu-Gln-Glu- 
Lys-Leu, with an amino terminal cysteine added) of the murine brain IP3R 
(Furuichi et al.,  1989) was synthesized using an ABI peptide synthesizer. 
10 nag of this synthetic peptide were coupled to keyhole lympet hemocyanin 
in  the  presence of 0.3%  glutaraldehyde  following  standard  protocols 
(Harlow and Lane,  1988).  A New Zealand White rabbit was immunized 
with 1 nag of peptide-keyhole lympet hemocyanin conjugate in complete 
Freund's adjuvant, followed by 0.5-mg booster injections subcutaneously at 
3, 5, and 7 wk in incomplete Freund's adjuvant. The rabbit was bled and 
serum obtained 12 d after the final injection. IgG was purified from the an- 
tiserum by passing through Econopac IgG purification columns (Pharmacia 
Fine Chemicals, Piscataway,  NJ). To affinity purify the IP3R antibody, syn- 
thetic  IP3R  peptide  (used  as  antigen)  was  coupled to  CNBr-activated 
Sepharose as per manufacturer's instructions (Pharmacia Fine Chemicals). 
5 mg of synthetic peptide was coupled to 1 g of CNBr-aetivated Sepharose 
and equilibrated in PBS. Purified IgG was then passed through the peptide- 
CNBr-activated Sepharose columns, washed with PBS, BBS-Tween (0.1 M 
boric acid, 25 mM sodium borate, 1 M sodium chloride, and 0.1% Tween 
20),  and  then  PBS  again.  The  bound  antibody  was  eluted  with 4  M 
gnanidine-HCl, 10 mM Tris, pH 8.0, and the eluate was dialyzed overnight 
against 50 mM Hepes, pH 7.4,  100 mM NaCI at 4~ 
The specificity of  the resulting anti-IP3R antibody was determined by im- 
munoblots of rat tissue homogenates. SDS-PAGE was performed on 1.0-mm 
thick 6 % gels. Size fractionated proteins were transferred to polyvinylidene 
difluoride membrane using a  semi-dry blotting apparatus from Bio-Rad 
Laboratories (Cambridge, MA) at 25 mV for 1 h. Membranes were prewet- 
ted with 100%  methanol, washed in distilled water, and equilibrated with 
Tris-glycine buffer, pH 8.3. Membranes were blocked with 5% dry milk in 
TBS (50 mM Tris-HC1, pH 7.4,  150 mM NaCI) at 23"C for 1 h. Blots were 
incubated with affinity-purified antibodies overnight at 4"C in the same 
buffer diluted at 1:50. Membranes were washed four times for 10 min each 
in PBST (PBS with Tween-20) then incubated with a  1/2,500 dilution of 
peroxidase-conjngated horse anti-rabbit Ig (Bio-Rad Laboratories) for 1 h. 
Immunodetection was carried out using ECL (chemiluminescence reagent; 
Amersham Corp., Arlington Heights, IL) followed by exposure to autora- 
diographic film. 
In Situ Hybridization Combined with 
Immunocytochemistry 
IP3R (rat) cDNAs were subcloned into pBluescript (Stratagene, La Jolla, 
CA) using standard methods (Sambrook et al.,  1989).  RNA probes for in 
situ hybridization were synthesized using either the T3 and T7 RNA poly- 
merases (Ambion Inc.). Antisense and sense probes were transcribed from 
linearized plasmids in the presence of 50 t~Ci [35S]CTP (New England Nu- 
clear, Boston, MA). A  1.0-kb antisense-strand cRNA probe was synthe- 
sized by linearizing R-IP3R-1 with HindIII and using T3 RNA polymerase; 
a  1.3-kb sense-strand probe was synthesized by linearizing R-IP3R-I with 
BamHI and using T7 RNA polymerase. Tissue samples from adult rat heart 
were prepared for in situ hybridization as described elsewhere with several 
modifications (Cox et al.,  1984;  Kinter and Melton, 1987).  Specifically, 
whole hearts were removed under anesthesia and fixed for 30 min in 4% 
paraformaldehyde in 0.1 M PBS. The hearts were subsequently cut along 
the sagittal plane and further fixed in 4% paraformaldehyde in 0.1 M PBS 
overnight. Tissue was cryoprotected in 0.5 M sucrose in 0.1 M PBS for 30 
min and further cryoprotected in 1 M sucrose and 0.1 M PBS for 30 to 45 
min. Tissue was frozen in Cryo-Embed compound in liquid nitrogen and 
stored at -80~  until use. Sections, 6-8-tLm thick, were obtained by using 
an IBHI (Hacber) cryostat and collected onto coated slides (Superfrost plus; 
Fisher Scientific Co.,  Pittsburgh,  PA).  Sections were refixed with 4% 
paraformaldehyde for 20 min, rinsed in 2x  SSPE, incubated for 30 min 
with proteinase K (3 mg/ml in 0.1 M Tris, pH 7.5, 0.01 M EDTA), rinsed, 
incubated in 0.2 N  HCI, rinsed, treated with acetic anhydride (0.25%  in 
0.1 M triethanolamine buffer,  pH 8.0) for 10 min, rinsed, and hybridized 
overnight. 
Hybridization was performed in 50% formamide, 0.3 M NaC1, 10% dex- 
tran sulfate, 2 mM EDTA, 1￿  Denhardt's, 0.01 M Tris HC1, pH 8, 0.05 M 
DTT.  Approximately 5-6  x  10  ~ cpm of each probe was applied to in- 
dividual slides. Slides were rinsed in 4x  SSPE and 10 mM DTT,  washed 
in 2x SSPE and 10 mM DTT for 1 h at room temperature, and treated with 
20/zg/ml RNAse in 4x SSPE and 10 mM DTT for 30 min at 37"C. Slides 
were then washed at 600C for 1 h in 50 % formamide, 2 x  SSPE and 10 mM 
DTT, transferred to 0.3 M ammonium acetate, 1% glycerol before dipping 
in NTB2 autoradingraphic emulsion (Eastman Kodak Co., Rochester, NY). 
Slides were exposed for 1 wk, developed in D-19 developer (Eastman Kodak 
Co.) for 2.5 rain, rinsed in 0.2% acetic acid for 10 s, fixed for 5 min, and 
rinsed in water. Slides were stained with hematoxilin to visualize the nuclei. 
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Zeiss, Oberkochen, Germany) equipped with a darkfield condenser. 
Additional  tissue sections were analyzed using combined in situ hybrid- 
ization and immunocytochemistry.  These sections were prepared as in the 
in situ hybridization  protocol (see above)  with the following  modifications: 
sections were fixed  in 4 % paraformaldehyde  in PBS for 20 min, rinsed once 
in 3 x PBS and twice in PBS for 5 rain, washed in 2x SSPE, and incubated 
with proteinase K (1.5 mg/ml) at 37~  for 15 rain 1 x  106 cpm of probe 
was added to the hybridization  solution. Washing  was with 55% formamide 
at 55~  Slides were washed  twice with PBS and prepared for immunocyto- 
chemical staining as per the protocol in the Vectastaln ABC kit (Vector 
Laboratories Inc., Buflingame, CA). Sections were pretreated with 0.3% 
hydrogen peroxide in methanol for 30 minutes at room temperature to 
quench endogenous  peroxidases followed  by washing  with PBS ￿  3 for  10 
min each. Sections were blocked with goat serum (vectastain) and in- 
cubated for 30 min at room temperature. On some sections primary anti- 
body was omitted after treatment with the goat serum. On these sections, 
stained with secondary antibody alone, no signal was detected (data not 
shown), indicating the absence of endogenous biotin and avidin which 
would  have yielded a positive signal if  present. Sections  were incubated  with 
either the anti-IP3R antibody (otlP3R-l),  control pre-immune serum or pre- 
absorbed serum (see below) at 1:50 dilution overnight at 4oc. After a 1-h 
incubation, the antigen-antibody complex was detected using biotinylated 
goat anti-rabbit IgG at a 1:300 dilution and ABC reagents (Vector Labora- 
tories Inc.). Peroxidase stain was developed with diaminobenzidene  tetra- 
hydrochloride  and the sections were then dipped in autoradiographic emul- 
sion following  dehydration in graded alcohols containing 0.3 M NHaAOc. 
To demonstrate that alP3R-1 was sequence-specific,  the antibody was 
pre-absorbed with an excess of the antigenic peptide (,,ol mg of IP3R pep- 
tide in 250 t~l of  a 1/50 dilution of  antiserum) by incubation  at room temper- 
ature for 2 h. (alP3R-1 antiserum incubated without antigenic peptide at 
room temperature for 2 h retained immunoreactivity  as determined by im- 
munostaining  of  heart tissue sections, see Fig. 7 A). Pre-absorbed antibody 
was tested against the antigenic peptide on dot blots and against the IP3R 
protein on immunoblots, demonstrating no reactivity. Pre-absorbed anti- 
body was used as a negative  control for immunocytochemistry  following  the 
protocol described above. 
Separately,  an antibody which recognizes  sarcomeric  myosin  heavy chain 
was used to identify cardiac myocytes  in adjacent sections to those used for 
IP3R detection. This antibody, MF20, was provided by Dr. Donald Fisch- 
man (Cornell University Medical College, New York, NY). Sections from 
the rat heart were examined for endogenous avidin and biotin which might 
result in higher background using the ABC-immunoperoxidase reagents 
and no significant background signal was detected (data not shown). 
Results 
Specificity of the IP3R Riboprobe 
IP3R riboprobes were synthesized from a  cDNA template 
encoding a  portion of the  rat aortic smooth  muscle IP3R 
(R-IP3R-1). This cDNA corresponds to nucleotides 98%2705 
of the  mouse  aortic  smooth  muscle  IP3R  (Marks  et  al., 
1990) and is >90%  identical to the mouse cDNA sequence. 
Fig. 1 shows the specificity of the antisense and sense IP3R 
riboprobes used for in situ hybridizations. As demonstrated 
in Fig. 1 the antisense IP3R riboprobe identifies a fully pro- 
tected fragment in total RNA from rat heart (Fig. 1, lane/), 
rat aortic smooth muscle cells (Fig. 1, lane 2), and rat brain 
(Fig. 1, lane 3). No hybridization is seen with the sense IP3R 
riboprobe corresponding to the  same sequence as the an- 
tisense (Fig.  1, lane 4), The undigested probe (Fig.  1, lane 
5) contains additional sequence from pBluescript vector and 
migrates slightly slower than the fully protected fragment. 
As a  negative control no hybridization was seen with yeast 
RNA added to either antisense or sense riboprobe (data not 
shown). 
Fig. 2 shows a Northern blot analysis of rat aortic smooth 
muscle total RNA demonstrating that a cDNA probe corre- 
sponding to the sequence of the riboprobe used for in situ 
Figure  L  RNAse  protection  showing  specificity of  the  IP3R 
riboprobes. Using the antisense-strand cRNA probe and total RNA 
(10/~g each sample) fully protected bands (870 nt, indicated by ar- 
row at left) are seen in: rat heart (lane/); rat aortic smooth muscle 
(lane 2), and rat brain (lane 3).  No protection is seen using the 
sense-strand probe with mouse heart RNA (lane 4). Lane 5 shows 
the full-length  probe (1,010 nt, indicated  by arrow at right). Molecu- 
lar weight markers are a labeled  ~X174 HaeM digest (New England 
Biolabs). 
hybridization binds to a  single "-10-kB mRNA.  A  long ex- 
posure (10 d) is shown to demonstrate that no hybridization 
to minor species is seen. 
Specificity of the IP3R Antibody 
Anti-IP3R antibody was raised in rabbits against a synthetic 
IP3R  peptide.  After affinity purification this  antibody re- 
acted with a  single •260-kD  band in a  crude rat heart ho- 
mogenate (Fig. 3, lane/) and rat brain homogenate (Fig. 3, 
Figure 2. Northern blot analysis demonstrating 
specificity  of  the IP3R probe. The IP3R mRNA 
was detected as a  single '~10-kb band in rat 
heart total RNA (30 #g) using an IP3R eDNA 
as probe corresponding to the sequence of the 
riboprobe used for in situ hybridization. The 
positions of the 28s and 18s ribosomal RNAs 
are depicted at left. 
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sis  demonstrating  specificity 
of the  rabbit  anti-IP3R anti- 
body.  Rat  heart  and  brain 
homogenates (30/~g total pro- 
tein) were size fractionated on 
a  6%  SDS-polyacrylamide 
gel,  blotted  to  a  polyvinyl- 
idene  difluoride  membrane, 
and  probed  with  atfinity- 
purified anti-IP3R antibodies. 
Lane 1, rat heart; lane 2, rat 
brain.  A single band migrat- 
ing at ~260,000 D is seen in 
both heart and brain, no addi- 
tional non-specific or specific 
binding  was  seen.  Antibody 
was used at a  1:50 dilution. 
Position of molecular weight 
markers are indicated: myosin (205 kD),  /~-galactosidase (116.5 
kD), BSA (prestained, migrates at 80 kD). 
lane 2). A  peptide blocking experiment was performed to 
further demonstrate the specificity of the o~-IP3R-1 antibody. 
~IP3R-1 antibody, pre-absorbed with buffer alone (PBS) re- 
tained immunoreactivity (see Fig. 7 A), however a-IP3R-1 
antibody, pre-absorbed with an excess of the antigenic syn- 
thetic IP3R peptide demonstrated no immunoreactivity (Fig. 
7  B),  This  experiment  indicates  the  specificity  of  the 
u-IP3R-1 antibody used for immunolocalization of the IP3R 
in cardiac myocytes. 
IP3R mRNA and Protein Are Expressed in 
Cardiac Myocytes 
To determine whether the IP3R is expressed in cardiac myo- 
cytes or in non-muscle ceils in the heart, combined in situ 
hybridization and immunocytochemistry was performed on 
whole heart sections from adult rat. IP3R protein was de- 
tected throughout the heart (Fig, 4, A, B, D, E, and F) and 
in smooth muscle cells of the aorta (positive control, Fig. 4 
C).  At  higher  magnification,  IP3R  protein  was  evident 
within the cardiac myocytes (Fig. 4, E and F). The identity 
of cells in which IP3R was detected was further established 
by detection of sarcomeric myosin heavy chain using an anti- 
myosin antibody (MF20) on sections adjacent to those used 
for the IP3R detection (data not shown). IP3R mRNA is de- 
tected in the wall of left ventricle and in papillary muscle 
(Fig. 5 A), in the structures surrounding the left ventricular 
outflow track (Fig. 5 B), the wall of the left atrium (Fig. 5 
C),  and  at the  apex of the  left ventricle (Fig.  5  E).  No 
significant signal above background is seen in a representa- 
tive section using  the  sense-strand riboprobe (Fig.  5  D). 
These sections are representative of sections throughout the 
heart, all of which showed signals for IP3R mRNA and pro- 
tein within the cardiac myocytes. In regions of the left ventri- 
cle which contained both cardiac myocytes and non-muscle 
cells (fibroblasts) no IP3R mRNA or protein was detected in 
the non-muscle cells (data not shown). 
The Signal for antisense IP3R riboprobe (Fig.  6 A) was 
compared to  that  for the  sense  riboprobe (Fig.  6  B)  in 
ascending aorta. No significant signal above background is 
seen in a representative section of the ascending aorta using 
the sense riboprobe, while substantial signal demonstrating 
IP3R mRNA is detected using the antisense riboprobe for 
IP3R. To demonstrate the specificity of the IP3R antibody 
used for immunocytochemistry (ot-IP3R-1), antibody stain- 
ing of left ventricular myocardium was compared to staining 
with control serum (Fig. 6, C and D). Staining a section of 
left ventricular myocardium with ot-IP3R-1 demonstrated the 
presence of IP3R in cardiac myocytes (Fig. 6 C), in contrast 
no signal was seen after staining with control serum (Fig. 6 
D). IP3R mRNA was detected by in situ hybridization in the 
vascular smooth muscle of an artery in the left ventricular 
myocardium (Fig.  8), 
Relative Amounts of  lP3R and RYR mRNAs in 
Cardiac Myocytes 
We also examined the relative abundance of IP3R and RYR 
transcripts in heart, aortic smooth muscle, and brain from 
rabbit using densitometric analyses of  Northern blots of total 
RNA (Fig. 9).  The level of RYR mRNA in the heart was 
•50-fold  higher than that of the 1P3R.  In contrast, in total 
RNA from aortic smooth muscle and brain, the IP3R mRNA 
was more abundant (approximately fivefold) than the RYR 
mRNA. These Northern blots are representative of multiple 
(/>3 for each tissue and probe) experiments performed on to- 
tal RNA isolated from several animals (I>6 for each tissue). 
GAPDH mRNA levels and 28s and 18s ribosomal RNA lev- 
els (by ethidium bromide staining) were used to control for 
the amounts of  RNA loaded in each lane. Similar results have 
been obtained using total RNA isolated from mouse tissues 
(data not shown). 
Discussion 
The present study demonstrates that an IP3R mRNA and 
protein are expressed in cardiac myocytes. While the domi- 
nant mechanism of E-C coupling in cardiac muscle is Ca  2+- 
induced Ca  2+ release, evidence has accumulated in favor of 
a role for IP3-induced Ca  2+ release as well.  An important 
Figure 4. Combined in situ hybridization and immunocytochemical localization of IP3R in the rat heart. An antisense 35S-labeled IP3R 
RNA probe was used for these studies (for details see Materials and Methods and Fig. 3 legend). Anti-IP3R peptide antibodies were used 
to stain rat heart tissue sections and were visualized using peroxidase (for details see Materials and Methods). (A) lmmunoreactive IP3R 
detected in a section showing the lumen of the left ventricular cavity with the left ventricular free wall (LV) facing a portion of  the papillary 
muscle (P). (B) Immunoreactive IP3R detected in the region of the left ventricular outflow tract including the wall of the ascending aorta 
(Ao)  just above the anterior leaflet of  the aortic valve (arrow). (C) Higher power bright field view of  the wall of the ascending aorta showing 
both immunoreactive IP3R and IP3R mRNA within aortic smooth muscle cells. (D) Section of the wall of the left atrium showing im- 
munoreactive IP3R. (E) High power bright field view of the apex of the left ventricular cavity showing immunoreaetive IP3R in cardiac 
myocytes. (F) Lower power bright field view of the same section as in E showing both immunoreactive IP3R and IP3R mRNA. Bars: 
(A, B, and D) 80/~m; (C and F) 40 #m; (E) 12.7 #m. 
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of the  rat  heart.  Antisense and  sense  asS-labeled IP3R  RNA 
probes were used for these studies as described in Materials and 
Methods. (.4) Darldield view of a section as in Fig. 4 A showing 
the IP3R mRNA in the left ventricular free wall (LV) and the 
papillary muscle (P).  (B)  Darkfield view  of the  same  section 
shown in Fig. 4 B, IP3R mRNA is visualized  in the ascending wall 
of the aorta, (Ao), and the adjacent left atrial cardiac myocytes. 
(C) Darkfield view of the same section shown in Fig. 4 D, IP3R 
mRNA is visualized in the left atrial wall. (D) Darkfield view of 
a section adjacent to that shown in C hybridized with the sense 
RNA probe, no signal above background is seen in this represen- 
tative field. (E) Darkfield view of the same section as shown in 
Fig. 4 F, IP3R mRNA is visualized in the cardiac myocytes at the 
apex of the left ventricular cavity. Bars: (A-D) 80 #m; (E) 40 ~m. 
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aorta and the anti-IP3R antibody (a-IP3R-1) in left ventricular myocardium. (A) Darkfield view of a section of ascending aorta labeled 
with antisense-strand IP3R riboprobe showing the IP3R mRNA. (B) Darldield view of an adjacent section of ascending aorta labeled with 
the sense-strand riboprobe showing no significant signal above background. (C) Left ventricular myocardium showing immunoreactive 
IP3R in cardiac myocytes. (D) An adjacent section of left ventricular myocardium stained with control pre-immune serum showing back- 
ground signal. Antisense and sense 35S-labeled IP3R RNA probes were used for these studies as described in Materials and Methods. 
Anti-IP3R peptide antibodies were used to stain rat heart tissue sections and were visualized using peroxidase (for details see Materials 
and Methods). Bars: (A and B) 80 #m; (C and D) 40 #m. 
Moschella and Marks IP3R Expression in Cardiac Myocytes  1143 Figure 8. In situ hybridization demonstrating IP3R mRNA detected 
in the myocardium and in the vascular smooth muscle surrounding 
an artery in the  left ventricular  myocardium.  An antisense  3sS- 
labeled IP3R RNA probe was prepared as described in Materials 
and Methods.  Bar, 40/~m. 
Figure  7.  Immunocytoehemistry  demonstrating  specificity of the 
anti-IP3R antibody. (A) Immunoreactive IP3R is detected in a sec- 
tion of the left atrium stained with anti-IP3R antibody (c~-IP3R-1) 
pre-absorbed  with buffer (PBS) alone. (B) An adjacent section of 
the left atrium stained with a-IP3R-1 antibody pre-absorbed  with 
the antigenic peptide  (anti-IP3R antibody was pre-absorbed  with 
~1 nag of IP3R peptide in 250/zl of a 1/50 dilution of antiserum 
incubated at room temperature for 2 h). No signal is detected with 
the pre-absorbed  antibody. Anti-IP3R peptide antibodies used to 
stain rat heart tissue sections were visualized using peroxidase (for 
details see Materials  and Methods).  Bars, 40 tzm. 
ent in most tissues,  but their structure has been identified 
only in brain and smooth muscle. 
In the heart,  a role for IP3-mediated pathways in excita- 
tion-contraction (E-C) coupling has been proposed based 
on studies suggesting IP3-induced calcium release and con- 
traction in cardiac muscle (Fabiato and Fabiato, 1984; Fabi- 
ato,  1990).  IP3-induced Ca  2+ release from cardiac SR has 
been shown in skinned ventricular fibers from rat (Kentish 
et al.,  1990) and cardiac SR vesicles (Hirata et al.,  1984). 
IP3 has also been shown to potentiate the effects of caffeine- 
induced  calcium  release  in  skinned  guinea  pig  papillary 
muscle (Nosek et al.,  1986).  Moreover, IP3-induced intra- 
cellular calcium release has been reported with high concen- 
prelude to determining the significance of IP3-induced Ca  2+ 
release in cardiac muscle is to establish that cardiac myo- 
cytes express an IP3R in addition to the cardiac RYR which 
mediates Ca2+-induced  Ca  2+ release. 
On the basis of immunoreactivity with a sequence-specific 
anti-IP3R antibody (Fig.  1) and RNAse protection using a 
smooth muscle IP3R cRNA probe (Fig.  3),  we have now 
shown that the IP3R expressed in cardiac myocytes is struc- 
turally most similar to the type 1 IP3R expressed in vascular 
smooth muscle and in the cerebellum (Furuichi et al., 1989; 
Marks et al.,  1990;  Mignery et al.,  1990). 
IP3Rs have been identified as functional intracellular cal- 
cium release channels in reconstituted vesicles (Ferris et al., 
1989)  and  in  lipid  bilayers  (MayrLeitner  et  al.,  1991). 
cDNAs encoding the IP3R have been cloned from mouse 
(Furuichi et al.,  1989) and rat (Mignery et al.,  1990) brain 
and  partially  cloned  from  mouse  aortic  smooth  muscle 
(Marks et al.,  1990)  revealing structural  similarity to the 
RYR/calcium release channel from the sarcoplasmic reticu- 
lum (Mignery et al.,  1989). IP3Rs are suspected to be pres- 
Figure  9.  Northern blot analyses demonstrating  relative levels of 
IP3R and RYR mRNAs in heart and smooth muscle. 20 #g of total 
RNA was isolated from the following rabbit tissues: H, heart; SM, 
aortic smooth muscle; and B, brain. Northern blot analysis was per- 
formed using eDNA probes for the cardiac RYR, aortic  smooth 
muscle IP3R, and GAPDH (see Materials  and Methods  for de- 
tails). In the heart, RYR mRNA is considerably more abundant that 
IP3R, whereas  there  is more IP3R mRNA in brain and smooth 
muscle. Hybridization of GAPDH is used to control for the amount 
of RNA loaded in each lane. Only the relevant portions of the blots 
are shown. Only  specific bands  corresponding  to the  indicated 
mRNAs  were seen. 
The Journal of Cell Biology, Volume 120, 1993  1144 trations of o~-adrenergic agonists in rat left ventricular mus- 
cle (Poggioli  et al.,  1986;  Otani et al.,  1988). 
In contrast, it has been reported that IP3 had no effect on 
isolated cardiac SR or in permeabilized myocytes (Movesian 
et al., 1985).  In general the rate and degree of IP3-induced 
Ca  ~+ release in the heart has been significantly lower than 
that observed for Ca2+-induced Ca  2+ release. Endothelin, a 
potent inducer of contraction in the heart, has also been im- 
plicated as an activator of IP3 response in cardiac myocytes 
(Lovenberg and Miller,  1990).  However,  it has  not been 
conclusively demonstrated that endothelin activates cardiac 
contractility via an IP3 pathway and subsequent release of in- 
tracellular  Ca  2+,  in  part  because  investigators  have  not 
previously known whether an IP3R is present in cardiac 
myocytes. 
Northern blot  and  RNAse  protection analyses of total 
heart RNA have demonstrated a  signal corresponding to 
IP3R mRNA (Marks et al.,  1990;  Nakagawa et al.,  1991). 
Taken together, these studies, albeit incomplete, have raised 
the possibility that the IP3R may be expressed in cardiac 
myocytes and therefore could be  involved in  physiologic 
modulation of cardiac contractility in response to pharmaco- 
logic agents and hormones. However, until the present study, 
it has not been possible to ascertain whether the IP3Rs de- 
tected in these earlier studies were expressed in cardiac myo- 
cytes or in non-muscle cells in the heart. 
The IP3R has a molecular weight of 313 kD based on the 
deduced amino acid sequence from cDNA cloning (Furuichi 
et al.,  1989;  Mignery et al.,  1990)  and an '~260,000 Mr, 
based  on protein  purification (Supattapone  et  al.,  1988; 
Chadwick et al., 1990; Mourey et al., 1990). The molecular 
mass of the native IP3Rs from brain and vas deferens, as de- 
termined by gel filtration, was ,,ol,000  kD (Mourey et al., 
1990) and ultrastructural analysis of the purified bovine aor- 
tic smooth muscle IP3R demonstrates fourfold symmetry 
(Chadwick et al., 1990). Thus, the functional IP3R/calcium 
release  channel  is  a  homotetramer  comprised  of  four 
~260,000 Mr subunits. Analysis of hydropathy plots of the 
deduced amino acid sequence led to the prediction that the 
IP3R  contains  multiple  (eight  or  nine)  transmembrane 
regions located near the carboxy terminus (Furuichi et al., 
1989; Mignery et al., 1990) and a large cytoplasmic region 
to which IP3 binds (Mignery and Sudhof, 1990). 
Three domains have been proposed for the IP3Rs, a ligand 
binding domain at the amino-terminal end, a coupling do- 
main presumably linking IP3  binding to  calcium release 
channel activation, and a carboxy-terminal channel region 
(Mignery et al., 1990; Ferris et al., 1991). The basic struc- 
ture is similar to that of the calcium release channels/RYRs 
of the sarcoplasmic reticulum. Two of these related calcium 
release channels, the skeletal and cardiac RYRs, have been 
well  characterized  (Marks  et  al.,  1989;  Mignery et  al., 
1989;  Takeshima et al.,  1989;  Marks,  1990;  Otsu et al., 
1990).  The RYRs are also large, symmetrical intracellular 
calcium release channels comprised of four identical sub- 
units. Structural similarities between RYRs and IP3Rs sug- 
gest that the two forms of intracellular calcium release chan- 
nels are members of a gene super family. 
Alternative  splicing  of  the  IP3R  transcript  has  been 
characterized (Mignery et al., 1990; Nakagawa et al., 1991) 
defining neuronal and non-neuronal forms (Danoff et al., 
1991). A second and third form of the IP3R have been cloned 
from rat cerebellum flP3R types 2 and 3)  (Sudhof et al., 
1991). An IP3R has also recently been characterized in hu- 
man T lymphocytes (Khan et al.,  1992). 
The level  of IP3R mRNA in the heart is considerably 
lower than that encoding the cardiac RYR, suggesting that 
the amount of  IP3R in the heart may be significantly  less than 
that of the RYR. This contrasts markedly with the brain and 
aortic smooth muscle, both of which express  more IP3R 
mRNA than RYR mRNA. Some of the IP3R mRNA signal 
detected in the total heart RNA is likely secondary to vascu- 
lar smooth muscle in the walls of arteries in the heart, thus 
the signal on Northern blot analysis probably overestimates 
the amount of IP3R mRNA in the cardiac myocytes. The dis- 
tribution of the IP3R in the heart suggests that it may have 
a role in regulating cytoplasmic calcium concentration in all 
regions of the heart including both ventricles and the atria. 
No striking regional differences in the level of IP3R mRNA 
or protein  expression  in  cardiac myocytes from different 
regions of the heart were seen. 
In the present study we demonstrated that the cDNA probe 
used for in situ hybridization is specific for IP3R mRNA 
(Fig. 1) and that the antibody used for immunocytochemistry 
is specific for IP3R protein (Fig. 3). Using conditions similar 
to those used for the combined in situ hybridization and im- 
munocytochemistry, the cRNA probe and anti-IP3R anti- 
body detected single, specific IP3R mRNA and protein sig- 
nals, respectively.  The subcellular localization of the IP3R 
in cardiac myocytes was not addressed. 
Recently, an IP3R was detected in both the intracellular 
and plasma membrane fractions in canine pancreatic homog- 
enates (Sharp et al., 1992) and on the plasma membrane of 
T ceils (Khan et al., 1992). These findings raise the possibil- 
ity that the IP3R detected in the heart may be located on 
multiple  distinct  membranes.  Differential localization of 
tritiated ryanodine and IP3  binding has been reported in 
brain and heart (Verma et al., 1992). IP3 binding was most 
prominent in the vascular smooth muscle surrounding arter- 
ies but was detected at lower levels throughout the rat heart 
in agreement with the findings of the present study. While 
IP3 is the major signal for contraction in smooth muscle 
(Somlyo, 1985), it appears to subserve a different, yet possi- 
ble physiologically significant role in cardiac muscle. The 
IP3R may determine calcium release from either an anatom- 
ically distinct pool of intracellular calcium in cardiac myo- 
cytes or directly from the SR. Demonstration that both forms 
of calcium release channels are expressed in cardiac myo- 
cytes raises the possibility that a complex feedback may exist 
involving interactions between the IP3R and the RYR cal- 
cium  pools.  IP3-sensitive  pathways  may  play  a  role  in 
regulating  cytoplasmic  calcium  concentration  in  cardiac 
muscle, this in turn may affect contractility. Alternative path- 
ways for regulating cytoplasmic calcium concentration may 
become more significant physiologically in disease states 
such as end-stage heart failure where we have recently shown 
that the cardiac RYR mRNA is down regulated (Brillantes 
et al.,  1992). 
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